Vaccine-induced immune thrombotic thrombocytopenia in a male after Ad26.COV2.S vaccination presenting as cerebral venous sinus thrombosis

References

• Thrombosis with thrombocytopenia syndrome (also termed vaccine-induced thrombotic thrombocytopenia). Thrombosis with Thrombocytopenia Syndrome - Hematology.org. Updated 2021 Dec 17[cited 2022 April 10]. Available from: https://www.hematology.org/covid-19/vaccine-induced-immune-thrombotic-thrombocytopenia
   Google Scholar
• Greinacher A, Selleng K, Palankar R, Wesche J, Handtke S, Wolff M, Aurich K, Lalk M, Methling K, Völker U, et al. Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. Blood 2021 Dec 2;138(22):2256–2268. doi:10.1182/blood.2021013231.
   PubMed Web of Science ®Google Scholar
• See I. Updates on Thrombosis with Thrombocytopenia Syndrome (TTS). Advisory Committee on Immunization Practices (ACIP). Published 2021 Dec 16[cited 2022 April 10]. Available from: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-12-16/02-COVID-See-508.pdf
   Google Scholar
• See I, Lale A, Marquez P, Streiff MB, Wheeler AP, Tepper NK, Woo EJ, Broder KR, Edwards KM, Gallego R, et al. Case series of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination-United States, December 2020 to August 2021. Ann Intern Med 2022 Jan 18:M21–4502. doi:10.7326/M21-4502. Epub ahead of print.
   Google Scholar
• Use of Janssen Covid-19 vaccine - adverse event - thrombosis. JanssenMD® professional information resource. Updated 2021 Dec 23[cited 2022 April 10]. Available from: https://www.janssenmd.com/janssen-covid19-vaccine/safety/adverse-events/thrombotic/use-of-janssen-covid19-vaccine-adverse-event-thrombosis
   Google Scholar
• Muir KL, Kallam A, Koepsell SA, Gundabolu K. Thrombotic thrombocytopenia after Ad26.COV2.S vaccination. N Engl J Med 2021 May 20;384(20):1964–1965. doi:10.1056/NEJMc2105869. Epub 2021 Apr 14.
   PubMed Web of Science ®Google Scholar
• Dhoot R, Kansal A, Handran C, Haykal T, Ronald J, Kappus M, Arepally GM, Graham M, Strouse JJ. Thrombocytopenia and splanchnic thrombosis after Ad26. COV2. S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy. Am J Hematol 2021;96(9):1180–1182. doi:10.1002/ajh.26258.
   PubMedGoogle Scholar
• Abou-Ismail MY, Moser KA, Smock KJ, Lim MY. Vaccine-induced thrombotic thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous thromboembolism. Am J Hematol 2021;96(9):E346–E349. doi:10.1002/ajh.26265.
   PubMedGoogle Scholar
• Shazley O, Alshazley M. A COVID-positive 52-year-old man presented with venous thromboembolism and disseminated intravascular coagulation following Johnson & Johnson vaccination: a case-study. Cureus 2021;13(7):e16383. Published 2021 Jul 14. doi:10.7759/cureus.16383.
   PubMedGoogle Scholar
• Kennedy VE, Wong CC, Hong JM, Peng T, Brondfield S, Reilly LM, Cornett P, Leavitt AD. VITT following Ad26.COV2.S vaccination presenting without radiographically demonstrable thrombosis. Blood Adv 2021;5(22):4662–4665. doi:10.1182/bloodadvances.2021005388.
   PubMed Web of Science ®Google Scholar
• Hussain H, Sehring M, Soriano S. Deep venous thrombosis after Ad26.COV2.S vaccination in adult male. Case Rep Crit Care 2021;2021:7682655. Published 2021 Oct 14. doi:10.1155/2021/7682655.
   PubMedGoogle Scholar
• Major A, Carll T, Chan CW, Christenson C, Aldarweesh F, Wool GD, Cohen KS. Refractory vaccine-induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE) [published online ahead of print, 2021 Oct 21]. J Clin Apher 2021. doi:10.1002/jca.21945.
   PubMedGoogle Scholar
• Rodríguez-Pardo J, Gilo-Arrojo F, Ruiz-Ares G, Sánchez-Manso JC, Valiente-Gordillo E, de Celis E, Fuentes B, Ximénez-Carrillo Á, de Leciñana MA, Rigual R, et al. Thrombosis and thrombocytopenia syndrome causing isolated symptomatic carotid occlusion after Covid-19 vaccine [published online ahead of print, 2021 Oct 20]. Thromb Haemost 2021. doi:10.1055/a-1674-0341.
   PubMedGoogle Scholar
• Castan M, Damin-Pernik M, Thiéry G, Page D, Smadja DM, Bertoletti L. A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson). Therapie 2022 Jan 31:S0040-5957(22)00016–6. doi:10.1016/j.therap.2022.01.014. Epub ahead of print.
   Google Scholar
• Murru V, Cocco V, Marras C, Sestu A, Marongiu F, Saba L, Cianchetti ME, Scuteri A. Acute embolisms in multiple arterial districts following Ad26.COV2-S vaccine. Eur Rev Med Pharmacol Sci 2022 Jan;26(1):278–283. doi:10.26355/eurrev_202201_27778.
   PubMedGoogle Scholar
• Curcio R, Gandolfo V, Alcidi R, Giacomino L, Campanella T, Casarola G, Rossi R, Chiatti L, D’Abbondanza M, Commissari R, et al. Vaccine-induced massive pulmonary embolism and thrombocytopenia following a single dose of Janssen Ad26.COV2.S vaccination. Int J Infect Dis 2022 Mar;116:154–156. doi:10.1016/j.ijid.2021.12.345. Epub 2022 Jan 2.
   PubMed Web of Science ®Google Scholar
• Asif S, Kesireddy M, Koepsell SA, Gonzalez-Castellon MA, Gundabolu K, Baljevic M. Cerebral venous sinus thrombosis due to thrombosis with thrombocytopenia syndrome following Ad26.COV2.S: a first real-world case report of a male subject. Neurohospitalist 2022;12(2):346–351. doi:10.1177/19418744211055065.
   PubMedGoogle Scholar
• Pavord S, Scully M, Hunt BJ, Lester W, Bagot C, Craven B, Rampotas A, Ambler G, Makris M. Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. N Engl J Med 2021 Oct 28;385(18):1680–1689. doi:10.1056/NEJMoa2109908. Epub 2021 Aug 11.
   PubMed Web of Science ®Google Scholar
• Schönborn L, Thiele T, Kaderali L, Greinacher A. Decline in pathogenic antibodies over time in VITT. N Engl J Med 2021 Nov 4;385(19):1815–1816. doi:10.1056/NEJMc2112760. Epub 2021 Sep 8.
   PubMed Web of Science ®Google Scholar
• MacNeil JR, Su JR, Broder KR, Guh AY, Gargano JW, Wallace M, Hadler SC, Scobie HM, Blain AE, Moulia D. Updated recommendations from the advisory committee on immunization practices for use of the Janssen (Johnson & Johnson) COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome among vaccine recipients — United States, April 2021. MMWR Morb Mortal Wkly Rep 2021;70:651–656. doi:10.15585/mmwr.mm7017e4.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. CDC endorses ACIP’s updated COVID-19 vaccine recommendations. CDC Newsroom; Published 2021 Dec 16[cited 2022 April 10]. Available from: https://www.cdc.gov/media/releases/2021/s1216-covid-19-vaccines.html
   Google Scholar